<DOC>
	<DOCNO>NCT02024217</DOCNO>
	<brief_summary>To investigate feasibility , safety tolerability Preoperative Chemoradiation Patients With Localized Gastric Cancer . Primary endpoint : R0 resection rate . Secondary endpoint : resection rate , pathological complete regression ( pCR ) , effectiveness safety regime , disease free survival ( DFS ) overall survival ( OS ) .</brief_summary>
	<brief_title>Neoadjuvant Chemotherapy Plus Chemoradiation Patients With Potentially Resectable Gastric Carcinoma</brief_title>
	<detailed_description>The prognosis gastric cancer poor partially due low R0 resection rate . Neoadjuvant chemoradiotherapy report effective set several phase II study . The investigator aim evaluate efficacy toxicity neoadjuvant chemoradiotherapy prospective phase II study .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Tegafur</mesh_term>
	<criteria>1.18 ≤ age ≤ 70 , Male Female ; 2.Minimum life expectancy 6 month ; 3.Patients localize , histologically confirm gastric gastroesophageal adenocarcinoma ; 4.Patients must performance status &lt; 2 Eastern Cooperative Oncology Group ( ECOG ) ; 5.No prior major surgery stomach radiation therapy stomach immunotherapy chemotherapy ; 6.CT MRI , endorectal ultrasonography ( EUS ) , laparoscopic exploration require stage ; 7.Without benign disease lung , kidney , liver infection ; 8.Without participate clinical trial ; 9.Patient must sign informed consent prior study entry ; 10.Patients must adequate bone marrow function ( defined peripheral absolute granulocyte count &gt; 1,500/µL , platelet count &gt; 100,000/µL ) , adequate liver function ( bilirubin &lt; = 1.5 mg/dl ) , adequate renal function ( creatinine &lt; = 1.5 mg/dl ) . 11 ) Patients without cardiac disease , severe uncontrolled diabetes , hypertension , cerebrovascular disease , infection . 1 . Pregnant woman exclude study entry due potential teratogenic effect study treatment ; 2 . Female patient plan baby ; 3 . Prior radiation therapy stomach , liver kidney ; 4 . Dysfunction important organ liver , kidney heart ; 5.Abnormalities mental status ; 6.Active coronary artery disease ; 7.Cardiac arrhythmia , need receive medication therapy ; 8.Severe uncontrolled hypertension ; 9.Active clinical serious infection ; 10.The know human immunodeficiency virus ( HIV ) infection history ; 11.The known central nervous system disease , include brain metastatic tumor ; 12.Patients clinical clear gastrointestinal bleed 6 month ; 13.Drug abuse ; 14.Swallowing difficulty drug ; 15.Poor compliance ; 16.Presence concurrent previous malignancy ( except cervical carcinoma situ basal cell carcinoma skin ) ; 17.Presence peritoneal metastasis , distant organ lymph nodes metastasis ; 18.Presence history major surgery past three month ; 19.Poor tolerability ; 20.Prior history medication ; 21.allergy chemotherapeutic drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>